{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:20:51Z","timestamp":1773325251287,"version":"3.50.1"},"reference-count":8,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.ajem.2016.11.038","type":"journal-article","created":{"date-parts":[[2016,11,15]],"date-time":"2016-11-15T18:31:38Z","timestamp":1479234698000},"page":"802.e7-802.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["The successful treatment of 5-fluorouracil (5-FU) overdose in a patient with malignancy and HIV\/AIDS with uridine triacetate"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2720-8912","authenticated-orcid":false,"given":"Cynthia","family":"Santos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brent W.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Geller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"129","key":"10.1016\/j.ajem.2016.11.038_bb0005","first-page":"38233","article-title":"Methods and compositions relating to detecting dihydropyridine dehydrogenase","volume":"73","author":"National Institutes of Health, Public Health Service","year":"2008","journal-title":"NIH, Federal Register"},{"key":"10.1016\/j.ajem.2016.11.038_bb0010","doi-asserted-by":"crossref","unstructured":"Bamat MK, Tremmel R, Eberwine SF, Garcia R, Saydoff JA, von Borstel R. Uridine triacetate for prevention of 5FU toxicity due to dihydropyrimidine dehydrogenase (DPD) deficiency. Journal of clinical oncology, 2011 ASCO annual meeting abstracts part 1. Vol 29, 15_suppl, 2011: e19560 (May 20 Supplement)","DOI":"10.1200\/jco.2011.29.15_suppl.e19560"},{"issue":"10","key":"10.1016\/j.ajem.2016.11.038_bb0015","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/01.COT.0000450350.19112.9c","article-title":"5-FU overdose may be countered by new antidote pill","volume":"36","author":"Susman","year":"2014","journal-title":"Oncology Times"},{"issue":"2","key":"10.1016\/j.ajem.2016.11.038_bb0025","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4143\/crt.2010.42.2.118","article-title":"A case of 5-fluorouracil induced encephalopathy","volume":"42","author":"Kyung","year":"2010","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.ajem.2016.11.038_bb0030","series-title":"Vistogard [package insert]","year":"2015"},{"issue":"2","key":"10.1016\/j.ajem.2016.11.038_bb0035","first-page":"43","article-title":"Fluorouracil overdose: clinical manifestations and comprehensive management during and after hospitalization","volume":"5","author":"Andreica","year":"2015","journal-title":"J Hematol Oncol Pharm"},{"key":"10.1016\/j.ajem.2016.11.038_bb0040","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2013.31.15_suppl.e20592","article-title":"Clinical experience with uridine triacetate for 5-FU overexposure: an update","volume":"31","author":"Bamat","year":"2013","journal-title":"J Clin Oncol"},{"issue":"19","key":"10.1016\/j.ajem.2016.11.038_bb0045","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.2146\/ajhp100434","article-title":"Use of uridine triacetate for the management of fluorouracil overdose","volume":"68","author":"McEvilly","year":"2011","journal-title":"Am J Health Syst Pharm"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073567571630866X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073567571630866X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:34:07Z","timestamp":1760024047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073567571630866X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S073567571630866X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2016.11.038","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The successful treatment of 5-fluorouracil (5-FU) overdose in a patient with malignancy and HIV\/AIDS with uridine triacetate","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2016.11.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}